| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 43.2866 | 19 |
| GSM780708 | Untreated after 4 days (C2_1) | 42.9443 | 17 |
| GSM780709 | Untreated after 4 days (C3_1) | 48.2692 | 42 |
| GSM780719 | Untreated after 4 days (C1_2) | 50.7384 | 51 |
| GSM780720 | Untreated after 4 days (C2_2) | 46.0861 | 32 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.5863 | 35 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 42.4638 | 15 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 49.8807 | 48 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 46.3894 | 34 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 53.5814 | 57 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 49.1953 | 46 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 48.9948 | 45 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 44.2518 | 23 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 49.7559 | 48 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 40.7074 | 8 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 42.9946 | 17 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 47.0624 | 37 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 44.9898 | 27 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 51.4536 | 53 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 51.6046 | 53 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 45.1805 | 28 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.9515 | 41 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 49.6107 | 47 |